Twenty hemodialysis were performed in six uremic patients with high bleeding risk, with a technique avoiding any anticoagulant drug before or during the treatment.
The treatment was well tolerated in all patients and no alterations were observed in the intrinsic clotting system evaluated before, during and after hemodialysis.
During the study, devices were never lost because of clotting or rupture, and their performances were similar to those obtained on heparin hemodialysis.
We suggest that in critically ill patients, needing dialysis, hemodialysis without heparin is possible and safe.
AbueloJ.G., ChangS.S.: Is prostacyclin better than nothing for anti coagulation in hemodialysis?Lancetii, 470, 1981.
2.
BernM.M.: Variable response of activated partial thromboplastin time to heparin therapy during hemodialysis.Am. J. Clin. Pathol.64: 602–607, 1975.
3.
BiggsR., MacFarlaneR.G.: Human blood coagulation and its disorders. In: Blackwell Scientific Publications, Oxford. 1962.
4.
BouayedF., RottembourgJ., DurandeJ.P., ElShahatY.: Successful regular hemodialysis session without any anticoagulant drug in patients with high bleeding risk. In: Proc. EDTA12, 1979 (abstr. book).
5.
CasatiS., PonticelliC.: Hemodialysis in patients with a risk of bleeding.New Engl. J. Med.305, 521–522, 1981.
6.
ChaneyA.L., MarbachF.P.: Modified reagents for determination of urea and ammonia.Clin. Chem.8: 130–2, 1962.
KingD.J., WootonI.D.P.: Micro Analysis in Medical Biochemistry.Fourth Edition, 174–175 (1964). L & A Churchill, London, England.
12.
LarrieuM.J., WeilandG.: Utilisation de la cephaline dans les tests de coagulation.Rev. Hemat.12, 199, 1957.
13.
LeeJ.H., CockerT.B., GonzalesF.M.: Regional vs ‘tight’ heparinization in hemodialysis.Proc. Clin. Dial. Transpl. Forum4: 239–246, 1974.
14.
MaherJ.F., LapierreL., SchereinerG.E., GeigerM., WesterveltF.B.Jr.: Regional heparinization for hemodialysis.N. Engl. J. Med.268: 451–456, 1963.
15.
MatsuiN., NakamuraY., ShinodaT., IwomotoH., YoshiyamaN., NakagawaS., TakeuchiJ., TeraokaJ.: The effect of heparin free dialysis on abnormal lipid metabolism in patients on regular dialysis treatment.In: Proc. EDTA17, 253, 1980.
16.
MoncadaS., GryglewskyR., BuntingS., VaneJ.R.: An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.Nature263, 663, 1976.
17.
ShapiroW.B., FaubertP.F., PorushJ.G., ChouShyan-yih: Low dose heparin in routine hemodialysis monitored by activated partial thromboplastin time.Artif. Organs3, 73, 1979.
18.
SwartzR.D., PortF.K.: Preventing hemorrhage in high risk hemodialysis: regional versus low dose heparin.Kidney int.16, 513, 1979.
19.
WoodsH.F., WestonM.J., BuntingS., MoncadaS., VaneJ.R.: Prostacyclin can replace heparin in hemodialysis in dogs.Lancetii, 1075, 1978.
20.
WoodsH.F., WestonM.J., BuntingS.: Hemodialysis without heparin.In Proc. EDTA15, 122, 1979.
21.
ZusmanR.M., RubinR.H., CatoA.E., CocchettoD.M., CrowJ.W., Tolkoff-RubinN.: Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent.N. Engl. J. Med.304, 934, 1981.
